Literature DB >> 18615481

The impact of T and N stage on long-term survival of rectal cancer patients in the community.

Kevin R Kozak1, John S Moody.   

Abstract

BACKGROUND AND OBJECTIVES: Use of the TNM staging system has been encouraged for rectal cancer patients. This study examined the impact of T and N stages on long-term survival as well as the performance of associated risk classification systems.
METHODS: Patients who underwent surgery for rectal adenocarcinoma from 1988 to 2004 were identified in the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier survival analysis was performed for subgroups of patients defined by T and N stage.
RESULTS: For the overall population of 30,826 patients, both T and N stage significantly impacted overall survival (P < 0.001). N stage variably affected survival for subgroups of patients based on T stage, whereas T stage significantly affected survival regardless of N stage. A previously developed risk classification system that assigns one of four risk levels outperformed AJCC group staging in this cohort. Based on long-term outcomes, a modified risk classification system was constructed which was highly prognostic for long-term overall survival (P < 0.001).
CONCLUSIONS: Rectal cancer patients experience widely varying survival rates based on extent of disease. A new risk classification system is proposed that provides better prognostic information than AJCC group staging, suggesting current rectal cancer staging systems may be improved with appropriate revisions.

Entities:  

Mesh:

Year:  2008        PMID: 18615481     DOI: 10.1002/jso.21107

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  9 in total

1.  An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all.

Authors:  M Medani; Niall Kelly; George Samaha; G Duff; Vourneen Healy; Elizabeth Mulcahy; Eoghan Condon; David Waldron; Jean Saunders; J Calvin Coffey
Journal:  Int J Colorectal Dis       Date:  2013-05-29       Impact factor: 2.571

2.  Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis.

Authors:  Rebecca I Hartman; Connie Y Chang; Jennifer Y Wo; Jonathan D Eisenberg; Theodore S Hong; Mukesh G Harisinghani; G Scott Gazelle; Pari V Pandharipande
Journal:  Acad Radiol       Date:  2012-09-02       Impact factor: 3.173

3.  Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer.

Authors:  E C M Zeestraten; M Maak; M Shibayama; T Schuster; U Nitsche; T Matsushima; S Nakayama; K Gohda; H Friess; C J H van de Velde; H Ishihara; R Rosenberg; P J K Kuppen; K-P Janssen
Journal:  Br J Cancer       Date:  2011-11-22       Impact factor: 7.640

Review 4.  The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.

Authors:  Eliane C M Zeestraten; Anne Benard; Marlies S Reimers; Philip C Schouten; Gerrit J Liefers; Cornelis J H van de Velde; Peter J K Kuppen
Journal:  Biomark Cancer       Date:  2013-07-04

5.  Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer.

Authors:  K Malinowsky; U Nitsche; K-P Janssen; F G Bader; C Späth; E Drecoll; G Keller; H Höfler; J Slotta-Huspenina; K-F Becker
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

6.  Biomarkers in precision therapy in colorectal cancer.

Authors:  Marlies S Reimers; Eliane C M Zeestraten; Peter J K Kuppen; Gerrit Jan Liefers; Cornelis J H van de Velde
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-08-23

7.  The impacts of surgery of the primary cancer and radiotherapy on the survival of patients with metastatic rectal cancer.

Authors:  Duo Tong; Fei Liu; Wenhua Li; Wen Zhang
Journal:  Oncotarget       Date:  2017-07-11

8.  LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.

Authors:  Yun-Ting Lou; Chao-Wen Chen; Yun-Ching Fan; Wei-Chiao Chang; Chien-Yu Lu; I-Chen Wu; Wen-Hung Hsu; Ching-Wen Huang; Jaw-Yuan Wang
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

9.  Apparent Diffusion Coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer.

Authors:  Yiqun Sun; Tong Tong; Sanjun Cai; Rui Bi; Chao Xin; Yajia Gu
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.